AI assistant
Sending…
SURMODICS INC — Director's Dealing 2021
Aug 13, 2021
32845_dirs_2021-08-13_335da64e-f54e-4784-ae55-f9385300f274.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: SURMODICS INC (SRDX)
CIK: 0000924717
Period of Report: 2021-08-11
Reporting Person: Manders John D. (Corporate Controller)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2021-08-11 | Common Stock | M | 2608 | $22.95 | Acquired | 5716 | Direct |
| 2021-08-11 | Common Stock | S | 2555 | $53.3312 | Disposed | 3161 | Direct |
| 2021-08-11 | Common Stock | S | 53 | $54.24 | Disposed | 3108 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2021-08-11 | Employee Stock Option (right to buy) | $22.95 | M | 2608 | Disposed | 2024-05-03 | Common Stock (2608) | Direct |
Footnotes
F1: Reflects the weighted average price of 2,555 shares of common stock of Surmodics,Inc. sold by the reporting person in multiple transactions on August 11, 2021 with sale prices ranging from $53.1458 to $53.72 per share. The reporting person undertakes to provide upon request by the U.S. Securities and Exchange Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price.
F2: Fully vested.
More from SURMODICS INC
Regulatory Filings
2025
Dec 1
Regulatory Filings
2025
Nov 21
Major Shareholding Notification
2025
Nov 20
Major Shareholding Notification
2025
Nov 20
Director's Dealing
2025
Nov 19
Director's Dealing
2025
Nov 19
Director's Dealing
2025
Nov 19
Director's Dealing
2025
Nov 19
Director's Dealing
2025
Nov 19
Director's Dealing
2025
Nov 19